Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jackson J Stewart

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
European Journal of Hospital Pharmacy : Science and Practice|July 8, 2026
The antimicrobial 'three-body problem'Jackson J Stewart, Bruce Dalton
International Journal of Antimicrobial Agents|September 4, 2020
Vancomycin AUC-guided therapeutic drug monitoring to reduce nephrotoxicity: are we overlooking a simpler solution? Comment on: Oda K, Jono H, Nosaka K, Saito H. Reduced nephrotoxicity in vancomycin therapeutic drug monitoring guided by area under the concentration-time curve against trough 15-20 µg/mL concentrationSarah C J Jorgensen, Jackson J Stewart, Bruce Dalton
JAMA Internal Medicine|May 5, 2025
Nitrites for Urinary Tract Infection-Time to Say Goodbye?Jackson J Stewart, Joan L Robinson, Justin Z Chen
The Journal of Antimicrobial Chemotherapy|July 10, 2021
The case for 'conservative pharmacotherapy'-authors' responseBruce R Dalton, Jackson J Stewart, Sarah C J Jorgensen
The Journal of Antimicrobial Chemotherapy|May 16, 2021
The case for 'conservative pharmacotherapy'-authors' responseSarah C J Jorgensen, Jackson J Stewart, Bruce R Dalton
The Journal of Antimicrobial Chemotherapy|February 1, 2021
The case for 'conservative pharmacotherapy'Sarah C J Jorgensen, Jackson J Stewart, Bruce R Dalton
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 12, 2021
'Limitations of classification and regression tree analysis in vancomycin exposure-response relationship studies' - Author's replyBruce R Dalton, Anish Krishnan, Jackson J Stewart, et al.
Pharmacotherapy|October 19, 2021
Comparison of risk-scoring systems for heparin-induced thrombocytopenia in cardiac surgery patientsJackson J Stewart, Ricky Turgeon, Arabesque Parker, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 31, 2021
Limitations of classification and regression tree analysis in vancomycin exposure-response relationship studies: insights from data simulationBruce R Dalton, Anish Krishnan, Jackson J Stewart, et al.
Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal Officiel De L'Association Pour La Microbiologie Medicale Et L'Infectiologie Canada|November 28, 2025
Appropriateness of intravenous vancomycin prescribing in a Canadian acute care hospitalHeather Glassman, Arif Ismail, Dima Kabbani, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
European Journal of Hospital Pharmacy : Science and Practice|July 8, 2026
The antimicrobial 'three-body problem'Jackson J Stewart, Bruce Dalton
International Journal of Antimicrobial Agents|September 4, 2020
Vancomycin AUC-guided therapeutic drug monitoring to reduce nephrotoxicity: are we overlooking a simpler solution? Comment on: Oda K, Jono H, Nosaka K, Saito H. Reduced nephrotoxicity in vancomycin therapeutic drug monitoring guided by area under the concentration-time curve against trough 15-20 µg/mL concentrationSarah C J Jorgensen, Jackson J Stewart, Bruce Dalton
JAMA Internal Medicine|May 5, 2025
Nitrites for Urinary Tract Infection-Time to Say Goodbye?Jackson J Stewart, Joan L Robinson, Justin Z Chen
The Journal of Antimicrobial Chemotherapy|July 10, 2021
The case for 'conservative pharmacotherapy'-authors' responseBruce R Dalton, Jackson J Stewart, Sarah C J Jorgensen
The Journal of Antimicrobial Chemotherapy|May 16, 2021
The case for 'conservative pharmacotherapy'-authors' responseSarah C J Jorgensen, Jackson J Stewart, Bruce R Dalton
The Journal of Antimicrobial Chemotherapy|February 1, 2021
The case for 'conservative pharmacotherapy'Sarah C J Jorgensen, Jackson J Stewart, Bruce R Dalton
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 12, 2021
'Limitations of classification and regression tree analysis in vancomycin exposure-response relationship studies' - Author's replyBruce R Dalton, Anish Krishnan, Jackson J Stewart, et al.
Pharmacotherapy|October 19, 2021
Comparison of risk-scoring systems for heparin-induced thrombocytopenia in cardiac surgery patientsJackson J Stewart, Ricky Turgeon, Arabesque Parker, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 31, 2021
Limitations of classification and regression tree analysis in vancomycin exposure-response relationship studies: insights from data simulationBruce R Dalton, Anish Krishnan, Jackson J Stewart, et al.
Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal Officiel De L'Association Pour La Microbiologie Medicale Et L'Infectiologie Canada|November 28, 2025
Appropriateness of intravenous vancomycin prescribing in a Canadian acute care hospitalHeather Glassman, Arif Ismail, Dima Kabbani, et al.
Pageof 2